Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Integrins01:10

Integrins

5.5K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.5K
Activation of Integrins01:15

Activation of Integrins

5.1K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.1K
Peptide Bonds02:43

Peptide Bonds

83.3K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.3K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.1K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.1K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

10.1K
10.1K
Overview of Exosomes01:36

Overview of Exosomes

3.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer.

Nanomedicine (London, England)·2026
Same author

Nanofibrillated cellulose hydrogel is a cryoprotectant in conventional and high temperature cryopreservation.

Cryobiology·2026
Same author

A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer.

Nanomedicine (London, England)·2026
Same author

Formation and cellular uptake of Bleomycin saccharide decorated molecular spherical nucleic acids evaluated by time-resolved fluorescence spectroscopy.

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2026
Same author

Towards a standardized diabetic prolonged wound healing model in hairless SKH1 mice.

Experimental biology and medicine (Maywood, N.J.)·2026
Same author

A Physiological Microfluidic Blood-Brain-Barrier Model for In Vitro Study of Nanoparticle Trafficking and Accumulation.

Advanced healthcare materials·2026

Related Experiment Video

Updated: Feb 8, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

13.0K

Targeting Tumor-Associated Exosomes with Integrin-Binding Peptides.

Randy P Carney1, Sidhartha Hazari1, Tatu Rojalin2

  • 1Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Advanced Biosystems
|June 19, 2018
PubMed
Summary

Researchers developed a peptide, LXY30, to target tumor-associated extracellular vesicles (EVs) by binding to α3β1 integrin. This enables differentiation of cancer EVs and shows potential for diagnostic and therapeutic applications.

Keywords:
biosensorcancerdiagnosticsexosomesoptical tweezers

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.6K

Related Experiment Videos

Last Updated: Feb 8, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

13.0K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.6K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nanotechnology

Background:

  • Extracellular vesicles (EVs) reflect cellular state and mediate cancer progression.
  • Tumor-associated EVs have distinct membrane proteins, offering diagnostic and therapeutic targets.
  • Current methods cannot distinguish EVs by origin or disease state in biofluids.

Purpose of the Study:

  • To demonstrate peptide binding to tumor-associated EVs via overexpressed membrane proteins.
  • To develop a method for differentiating cancer-associated exosomes from non-cancer exosomes.
  • To establish a detection platform for tumor-EVs and explore therapeutic potential.

Main Methods:

  • Utilized SKOV-3 ovarian tumor cells and their EVs.
  • Employed a cyclic nonapeptide, LXY30, targeting α3β1 integrin.
  • Applied flow cytometry and Raman spectral analysis of single exosomes.

Main Results:

  • LXY30 specifically binds to α3β1 integrin on SKOV-3 EVs.
  • Raman spectroscopy differentiated cancer-associated exosomes from non-cancer exosomes.
  • Immobilized LXY30 formed the basis of a tumor-EV detection platform.
  • LXY30 reduced EV uptake into parent cells, indicating therapeutic potential.

Conclusions:

  • Peptide LXY30 effectively targets tumor-associated EVs expressing α3β1 integrin.
  • A novel method for distinguishing cancer EVs using Raman spectroscopy was established.
  • The study lays the groundwork for specific tumor-EV detection and potential therapeutic interventions.